Status:

COMPLETED

Feasibility and Efficacy of Individual SH+ Intervention

Lead Sponsor:

Koç University

Conditions:

Grief Disorder, Prolonged

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The central aim of this research is to execute a randomized controlled trial (RCT) to assess the impact and effectiveness of the individually-delivered SH+ intervention among earthquake survivors in T...

Detailed Description

On February 6 2023, Türkiye experienced two consecutive major earthquakes measuring 7.6 and 7.8 on the Richter scale, resulting in extensive devastation across 11 provinces. According to data provided...

Eligibility Criteria

Inclusion

  • To be eligible for participation in this study, an individual must satisfy all of the following conditions:
  • Age 18 years or older
  • Have directly experienced the earthquake
  • Exhibit elevated levels of psychological distress, indicated by a score exceeding 15 on the Kessler Psychological Distress Scale (K10) (Kessler et al., 2002)
  • Display impaired psychosocial functioning, as evidenced by a score surpassing 16 on the WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) (WHO, 2010)

Exclusion

  • An individual meeting any of the subsequent criteria will not be included in this study:
  • Presence of acute medical conditions
  • Manifestation of imminent suicide risk or demonstration of acute needs/protection risks (assessed with Problem Management Plus (PM+) manual suicidality assessment)
  • Affliction with severe mental disorders, such as psychotic disorders or substance dependence (assessed with PM+ manual, observation checklist),
  • Experience of severe cognitive impairment, encompassing conditions like severe intellectual disability or dementia (PM+ manual observation checklist)
  • Current utilization of mental health care Participants meeting exclusion criteria will be referred for appropriate treatment as required.

Key Trial Info

Start Date :

October 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 24 2024

Estimated Enrollment :

37 Patients enrolled

Trial Details

Trial ID

NCT06091540

Start Date

October 1 2024

End Date

December 24 2024

Last Update

February 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Koc University

Istanbul, Turkey (Türkiye)